跳至主要内容
临床试验/NCT05469607
NCT05469607招募中不适用

The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

Austin Health2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2022年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Austin Health
入组人数
13
试验地点
2
主要终点
Safety and efficacy based on endoscopic recurrence

研究概览

简要总结

The purpose of this study is to evaluate the safety of vagal nerve neuromodulation in a cohort of patients operated on for Crohn's disease, in a prospective, single centre, cohort study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients aged 18 years or older with Crohn's disease who undergo resection with an endoscopically accessible primary anastomosis which results in macroscopic normality.
  • Patients having a reversal of a temporary ileostomy created after previous surgery for Crohn's disease may be enrolled provided that the reversal of the ileostomy results in a primary anastomosis and macroscopic normality of the remaining bowel.
  • Patients with co-existing perianal disease may be included provided the resection has led to a primary anastomosis and macroscopic normality of the intestine.
  • Patients must have proven history of Crohn's disease based on (clinical, radiologic, endoscopic and histologic criteria).

排除标准

  • Patients with anastomosis which is endoscopically inaccessible by standard colonoscopy.
  • Patients in whom there is persisting macroscopic abnormality post-surgical resection.
  • Patients with Crohn's disease who have an end stoma (ileostomy or colostomy).
  • Patients for whom endoscopy is not suitable due to co-morbidities or unwell clinical state
  • Inability to give informed consent.
  • Inability to obtain access to the anastomosis at colonoscopy.
  • Suspected perforation of the gastrointestinal tract.
  • Patients who are pregnant or breastfeeding.

结局指标

主要结局

Safety and efficacy based on endoscopic recurrence

时间窗: 6 months post-operation

Recurrence defined as the presence of any aphthous ulcers, and severe recurrence defined as an endoscopic Rutgeerts score ≥ 2 (5 aphthous ulcers or larger ulcers confined to the anastomosis)

次要结局

  • Surgical recurrence(6 and 18 months post-operation)
  • Clinical recurrence(6 months and 18 months post-operation)
  • Endoscopic recurrence(18 months post-operation)

研究者

发起方
Austin Health
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr Peter De Cruz

Head of Inflammatory Bowel Disease Unit

Austin Health

研究点 (2)

Loading locations...

相似试验

The ElectRx Study - A Neurotechnology Approach to... | 临床试验